Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.71 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 51.54.
Market Cap
9.71T
Revenue
4.67T
Profits
188.39B
PE Ratio
51.54
Profit Margin
4.03%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.16T | 2.83% | 2,660,305 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 644.91B | 3.81% | 10,130,678 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 503.96B | 0.14% | 6,174,194 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 381.46B | 1.91% | 5,423,002 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 363.27B | -1.76% | 19,031,456 | 66.57B |
| 6 | NVS | Novartis AG | 297.48B | 1.52% | 2,081,351 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 269.09B | 2.45% | 2,773,342 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 250.15B | -2.52% | 3,599,970 | 47.35B |
| 9 | AMGN | Amgen Inc. | 241.81B | 2.04% | 3,103,972 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 194.91B | 2.36% | 6,210,076 | 30.46B |
| 11 | ABT | Abbott Laboratories | 177.38B | 1.99% | 10,652,926 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 175.46B | 0.95% | 8,560,715 | 50.34B |
| 13 | PFE | Pfizer Inc. | 173.38B | 1.91% | 28,703,683 | 63.70B |
| 14 | DHR | Danaher Corporation | 161.64B | -1.76% | 7,067,049 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 153.86B | 3.67% | 2,778,943 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 135.64B | 2.03% | 1,641,551 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.69B | 3.08% | 15,169,242 | 49.19B |
| 18 | CVS | CVS Health Corporation | 120.84B | 1.83% | 7,226,532 | 412.65B |
| 19 | MDT | Medtronic plc | 118.24B | 3.83% | 8,880,448 | 37.54B |
| 20 | MCK | McKesson Corporation | 118.03B | -0.31% | 629,450 | 410.98B |
| 21 | SYK | Stryker Corporation | 117.79B | 3.19% | 2,804,734 | 25.84B |
| 22 | GSK | GSK plc | 102.51B | 2.38% | 4,283,403 | 44.05B |
| 23 | HCA | HCA Healthcare, Inc. | 101.17B | 1.72% | 872,796 | 78.01B |
| 24 | SNY | Sanofi | 100.60B | 2.42% | 3,458,665 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 96.21B | 2.57% | 1,428,162 | 201.83B |
| 26 | CI | The Cigna Group | 83.47B | 3.78% | 1,575,640 | 282.38B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 81.79B | 1.67% | 852,233 | 15.53B |
| 28 | MRNA | Moderna, Inc. | 80.90B | -17.57% | 49,995,068 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 66.68B | 3.37% | 16,394,703 | 21.00B |
| 30 | COR | Cencora, Inc. | 64.59B | -0.57% | 1,183,277 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 64.47B | 2.16% | 3,461,934 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 59.20B | -0.71% | 1,497,866 | 254.25B |
| 33 | NTRA | Natera, Inc. | 57.86B | -2.91% | 1,611,573 | 2.71B |
| 34 | ARGX | argenx SE | 54.89B | -1.61% | 1,020,770 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 54.59B | 3.13% | 1,382,832 | 22.48B |
| 36 | VEEV | Veeva Systems Inc. | 52.22B | 0.62% | 1,435,687 | 3.46B |
| 37 | EW | Edwards Lifesciences Corporation | 51.93B | 1.91% | 3,054,075 | 6.51B |
| 38 | HUM | Humana Inc. | 50.55B | -1.05% | 1,811,756 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 49.02B | -2.17% | 2,654,552 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.86B | -1.01% | 4,068,838 | 17.32B |
| 41 | MDLN | Medline Inc. | 45.86B | -1.22% | 14,959,858 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 45.81B | 0.61% | 1,672,431 | 16.98B |
| 43 | HLN | Haleon plc | 45.06B | 3.49% | 14,622,372 | 14.80B |
| 44 | WAT | Waters Corporation | 44.76B | -0.41% | 1,267,657 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 44.65B | 2.40% | 430,083 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 43.46B | -1.08% | 359,351 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 40.68B | -4.76% | 2,223,692 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 40.23B | -3.39% | 1,485,089 | - |
| 49 | BIIB | Biogen Inc. | 37.51B | 5.34% | 2,237,247 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 36.66B | 2.57% | 2,808,458 | 2.54B |
| 51 | RMD | ResMed Inc. | 35.59B | 2.79% | 1,886,240 | 5.65B |
| 52 | CNC | Centene Corporation | 35.19B | 1.42% | 4,696,099 | 180.30B |
| 53 | ALC | Alcon Inc. | 33.95B | 4.75% | 2,207,911 | 10.86B |
| 54 | ZTS | Zoetis Inc. | 33.88B | 2.99% | 4,828,389 | 9.53B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.75B | 0.40% | 230,303 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.26B | 3.49% | 3,128,908 | 21.27B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.41B | 0.97% | 2,212,202 | 4.80B |
| 58 | DXCM | DexCom, Inc. | 29.55B | -2.42% | 10,793,965 | 4.97B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.73B | 0.14% | 679,941 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 27.05B | 1.77% | 13,451,943 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 26.85B | 1.82% | 1,686,020 | 11.84B |
| 62 | LH | Labcorp Holdings Inc. | 26.76B | 1.91% | 961,977 | 14.35B |
| 63 | PHG | Koninklijke Philips N.V. | 26.17B | 2.63% | 1,192,131 | 20.18B |
| 64 | UTHR | United Therapeutics Corporation | 25.08B | 3.78% | 895,436 | 3.15B |
| 65 | GMAB | Genmab A/S | 23.76B | 1.09% | 4,685,572 | 4.13B |
| 66 | INCY | Incyte Corporation | 23.70B | 3.08% | 2,236,051 | 5.82B |
| 67 | STE | STERIS plc | 22.64B | 4.85% | 1,024,629 | 6.04B |
| 68 | BNTX | BioNTech SE | 22.53B | -1.77% | 1,146,184 | 3.03B |
| 69 | GH | Guardant Health, Inc. | 21.87B | -2.23% | 1,923,320 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.79B | 0.56% | 590,186 | 21.81B |
| 71 | VTRS | Viatris Inc. | 21.23B | 0.16% | 5,435,601 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.76B | 1.08% | 3,099,480 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.85B | 4.16% | 2,224,195 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.29B | -1.29% | 893,815 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.56B | 0.48% | 1,779,725 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 16.21B | -1.51% | 2,662,390 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.18B | 1.13% | 1,710,316 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 15.96B | 1.71% | 539,136 | 1.20B |
| 79 | SOLV | Solventum Corporation | 14.89B | 0.90% | 769,891 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.57B | 1.40% | 1,244,522 | 3.37B |
| 81 | ICLR | ICON Public Limited Company | 14.31B | 0.17% | 1,018,446 | 8.29B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.14B | -0.23% | 5,097,450 | 1.66B |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 13.93B | 1.26% | 783,793 | 4.60B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 0.56% | 2,780,398 | 713.07M |
| 85 | BAX | Baxter International Inc. | 13.26B | 3.85% | 5,204,979 | 11.47B |
| 86 | PEN | Penumbra, Inc. | 12.80B | 0.43% | 472,546 | 1.50B |
| 87 | SNN | Smith & Nephew plc | 12.69B | 5.64% | 1,638,719 | 6.30B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.68B | -2.41% | 2,146,538 | 14.37B |
| 89 | SMMT | Summit Therapeutics Inc. | 12.44B | -1.77% | 4,150,760 | - |
| 90 | EHC | Encompass Health Corporation | 12.43B | 4.60% | 1,227,999 | 6.21B |
| 91 | DVA | DaVita Inc. | 11.87B | 5.25% | 931,347 | 14.01B |
| 92 | COO | The Cooper Companies, Inc. | 11.72B | 4.54% | 3,510,084 | 4.24B |
| 93 | FMS | Fresenius Medical Care AG | 11.63B | 3.11% | 1,117,471 | 22.19B |
| 94 | CORT | Corcept Therapeutics Incorporated | 11.62B | -7.55% | 737,285 | 830.81M |
| 95 | AVTR | Avantor, Inc. | 11.60B | -0.64% | 12,740,517 | 6.56B |
| 96 | TEM | Tempus AI, Inc. | 11.51B | -5.83% | 6,204,216 | 1.43B |
| 97 | TECH | Bio-Techne Corporation | 11.39B | -0.03% | 4,161,605 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.34B | 0.62% | 4,452,451 | 5.02B |
| 99 | MOH | Molina Healthcare, Inc. | 11.29B | 0.81% | 1,815,464 | 42.08B |
| 100 | UHS | Universal Health Services, Inc. | 11.09B | 2.88% | 489,154 | 18.11B |
| 101 | ALGN | Align Technology, Inc. | 11.05B | 2.74% | 1,160,167 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 10.96B | 3.79% | 1,293,941 | 3.14B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.96B | 2.57% | 2,396,853 | 3.41B |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.90B | 0.30% | 3,983,257 | 3.50B |
| 105 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.47B | -1.01% | 212,688 | 1.28B |
| 106 | GKOS | Glaukos Corporation | 10.42B | -0.09% | 885,755 | 612.84M |
| 107 | QGEN | Qiagen N.V. | 10.39B | 0.44% | 40,827,264 | 2.10B |
| 108 | ENSG | The Ensign Group, Inc. | 10.31B | 2.88% | 307,789 | 5.49B |
| 109 | OSCR | Oscar Health, Inc. | 10.27B | -0.39% | 4,363,796 | 15.32B |
| 110 | PODD | Insulet Corporation | 10.27B | 4.38% | 1,213,701 | 3.05B |
| 111 | RGEN | Repligen Corporation | 10.09B | -0.72% | 1,272,416 | 785.10M |
| 112 | PCVX | Vaxcyte, Inc. | 9.89B | -0.60% | 2,771,275 | - |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.72B | 0.83% | 228,220 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.58B | 1.16% | 2,075,064 | 13.60B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.48B | -0.63% | 245,132 | 440.48M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.22B | -1.58% | 850,254 | 105.00M |
| 117 | TXG | 10x Genomics, Inc. | 9.09B | -7.73% | 4,189,902 | 616.91M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.03B | 1.05% | 404,382 | 281.99M |
| 119 | CAI | Caris Life Sciences, Inc. | 8.96B | -1.98% | 2,422,785 | 989.61M |
| 120 | HNGE | Hinge Health, Inc. | 8.87B | -1.85% | 2,264,038 | 720.06M |
| 121 | IBRX | ImmunityBio, Inc. | 8.81B | -3.82% | 12,735,648 | 165.79M |
| 122 | BRKR | Bruker Corporation | 8.73B | -3.05% | 2,371,664 | 3.50B |
| 123 | CYTK | Cytokinetics, Incorporated | 8.67B | -0.84% | 2,061,177 | 67.67M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.63B | -0.67% | 802,946 | - |
| 125 | TWST | Twist Bioscience Corporation | 8.49B | -9.16% | 2,691,591 | 431.80M |
| 126 | HQY | HealthEquity, Inc. | 8.35B | 3.16% | 1,253,825 | 1.36B |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.24B | -0.82% | 1,036,454 | 669.50M |
| 128 | AXSM | Axsome Therapeutics, Inc. | 8.18B | -0.15% | 832,343 | 776.57M |
| 129 | ATR | AptarGroup, Inc. | 8.14B | 1.97% | 426,358 | 3.93B |
| 130 | ABVX | ABIVAX Société Anonyme | 7.98B | -3.49% | 896,113 | 5.33M |
| 131 | TGTX | TG Therapeutics, Inc. | 7.54B | -0.08% | 1,289,120 | 799.54M |
| 132 | PACS | PACS Group, Inc. | 7.52B | 1.58% | 667,174 | 5.55B |
| 133 | ALKS | Alkermes plc | 7.41B | 1.61% | 1,833,975 | 1.67B |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.30B | -0.81% | 5,011,922 | 874.09M |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 7.23B | 0.96% | 355,672 | 7.46M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.13B | 1.39% | 6,036,675 | 3.12B |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.80B | -0.27% | 8,473,871 | 2.58B |
| 138 | CHE | Chemed Corporation | 6.77B | 1.72% | 141,445 | 2.60B |
| 139 | GRFS | Grifols, S.A. | 6.71B | -0.67% | 482,544 | 8.48B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.14% | 1,210,871 | 1.56B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.41B | -3.28% | 10,769,802 | 324.97M |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.30B | 1.37% | 429,607 | 840.85M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.26B | 2.57% | 516,393 | 239.92M |
| 144 | BLCO | Bausch + Lomb Corporation | 6.23B | 1.46% | 426,368 | 5.32B |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.14B | -2.21% | 315,128 | 290.54M |
| 146 | BLTE | Belite Bio, Inc | 6.05B | -1.90% | 125,652 | - |
| 147 | IMVT | Immunovant, Inc. | 6.01B | 2.54% | 1,157,165 | - |
| 148 | DOCS | Doximity, Inc. | 6.00B | 0.30% | 2,846,474 | 655.57M |
| 149 | TFX | Teleflex Incorporated | 5.79B | 4.74% | 697,968 | 2.25B |
| 150 | MANE | Veradermics, Incorporated | 5.79B | 1.34% | 794,348 | - |
| 151 | GRAL | GRAIL, Inc. | 5.68B | -4.18% | 652,994 | 165.26M |
| 152 | MMSI | Merit Medical Systems, Inc. | 5.61B | 2.78% | 655,038 | 1.58B |
| 153 | WAY | Waystar Holding Corp. | 5.56B | 0.49% | 1,947,899 | 1.21B |
| 154 | CGON | CG Oncology, Inc. | 5.54B | 0.55% | 579,516 | 6.23M |
| 155 | RDNT | RadNet, Inc. | 5.53B | 2.70% | 318,367 | 2.27B |
| 156 | COGT | Cogent Biosciences, Inc. | 5.43B | -0.38% | 1,178,290 | - |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.40B | -0.41% | 420,914 | 618.07M |
| 158 | KOD | Kodiak Sciences Inc. | 5.38B | -2.21% | 592,747 | - |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.37B | 1.54% | 589,923 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.33B | 3.61% | 961,517 | 1.40B |
| 161 | HAE | Haemonetics Corporation | 5.28B | -0.81% | 365,125 | 1.35B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.26B | 0.67% | 674,946 | 1.01B |
| 163 | SHC | Sotera Health Company | 5.17B | 2.03% | 2,797,513 | 1.22B |
| 164 | MMED | MiniMed Group, Inc. | 5.15B | 2.75% | 9,781,685 | 3.22B |
| 165 | SRRK | Scholar Rock Holding Corporation | 5.11B | -2.42% | 1,133,533 | - |
| 166 | CON | Concentra Group Holdings Parent, Inc. | 5.10B | 2.25% | 1,277,185 | 2.29B |
| 167 | BLLN | BillionToOne, Inc. | 4.99B | 0.96% | 377,556 | 397.41M |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.94B | -0.29% | 1,774,177 | 591.33M |
| 169 | ERAS | Erasca, Inc. | 4.91B | -3.11% | 2,295,979 | - |
| 170 | RGC | Regencell Bioscience Holdings Limited | 4.86B | -9.17% | 275,440 | - |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.84B | 1.44% | 2,112,504 | - |
| 172 | CRSP | CRISPR Therapeutics AG | 4.83B | -1.01% | 905,678 | 13.39M |
| 173 | HTFL | HeartFlow, Inc. | 4.82B | -0.70% | 1,296,274 | 212.07M |
| 174 | LFST | LifeStance Health Group, Inc. | 4.80B | 1.87% | 4,162,916 | 1.58B |
| 175 | TNGX | Tango Therapeutics, Inc. | 4.71B | 3.52% | 5,963,156 | 53.81M |
| 176 | OPCH | Option Care Health, Inc. | 4.69B | 0.03% | 1,517,822 | 5.69B |
| 177 | LIVN | LivaNova PLC | 4.48B | 3.61% | 522,976 | 1.47B |
| 178 | DNTH | Dianthus Therapeutics, Inc. | 4.39B | 0.61% | 1,480,220 | 1.90M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.34B | 0.86% | 1,337,723 | - |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | -0.11% | 1,493,109 | 1.84B |
| 181 | ICUI | ICU Medical, Inc. | 4.21B | 4.66% | 241,697 | 2.16B |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.17B | 1.55% | 871,659 | 1.33B |
| 183 | ARQT | Arcutis Biotherapeutics, Inc. | 4.05B | 1.04% | 2,075,747 | 463.98M |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.02B | -0.38% | 1,721,972 | 10.35M |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.94B | 5.36% | 501,709 | 825.34M |
| 186 | ADPT | Adaptive Biotechnologies Corporation | 3.90B | -3.63% | 1,258,706 | 308.08M |
| 187 | NVST | Envista Holdings Corporation | 3.85B | 3.36% | 3,373,419 | 2.86B |
| 188 | NHC | National HealthCare Corporation | 3.81B | 3.17% | 207,870 | 1.56B |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.76B | 2.67% | 421,421 | 1.19M |
| 190 | VCYT | Veracyte, Inc. | 3.70B | -0.39% | 1,203,501 | 561.90M |
| 191 | ABCL | AbCellera Biologics Inc. | 3.68B | -7.11% | 4,277,110 | 66.17M |
| 192 | LEGN | Legend Biotech Corporation | 3.66B | 1.45% | 1,197,787 | 1.27B |
| 193 | OGN | Organon & Co. | 3.61B | - | 2,553,567 | 6.13B |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.59B | -1.58% | 1,307,906 | -665.00K |
| 195 | CDNA | CareDx, Inc. | 3.58B | -2.23% | 917,863 | 458.09M |
| 196 | LQDA | Liquidia Corporation | 3.55B | 2.14% | 3,533,108 | 450.91M |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.53B | 1.53% | 1,375,502 | 7.50M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.50B | 0.59% | 1,229,378 | 1.14B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 1.83% | 603,063 | 234.13M |
| 200 | IRON | Disc Medicine, Inc. | 3.33B | -1.28% | 1,585,524 | - |
| 201 | PBLS | Parabilis Medicines, Inc. | 3.33B | -3.34% | 926,144 | 148.00K |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.26B | -4.89% | 734,013 | 890.79M |
| 203 | CELC | Celcuity Inc. | 3.21B | 6.51% | 1,932,771 | - |
| 204 | WRBY | Warby Parker Inc. | 3.17B | 0.16% | 2,517,236 | 911.61M |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 3.16B | 2.24% | 688,649 | 606.33M |
| 206 | ELVN | Enliven Therapeutics, Inc. | 3.07B | 0.26% | 2,324,851 | - |
| 207 | ATRC | AtriCure, Inc. | 3.02B | 2.83% | 498,172 | 569.62M |
| 208 | VKTX | Viking Therapeutics, Inc. | 3.01B | -2.08% | 3,530,547 | - |
| 209 | DNLI | Denali Therapeutics Inc. | 2.98B | -0.11% | 816,743 | 3.60M |
| 210 | ACHC | Acadia Healthcare Company, Inc. | 2.97B | 1.43% | 1,263,788 | 3.37B |
| 211 | DYN | Dyne Therapeutics, Inc. | 2.94B | -1.87% | 2,052,545 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.92B | 1.85% | 984,008 | 2.36B |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.91B | 2.54% | 1,777,658 | 2.60B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -1.96% | 1,933,847 | 701.94M |
| 215 | NEOG | Neogen Corporation | 2.62B | 1.61% | 2,881,930 | 884.00M |
| 216 | VRDN | Viridian Therapeutics, Inc. | 2.59B | -0.83% | 1,545,890 | 71.13M |
| 217 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | 0.42% | 1,703,250 | 7.12M |
| 218 | CLOV | Clover Health Investments, Corp. | 2.51B | -1.05% | 3,189,699 | 2.48B |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | 1.56% | 252,888 | 1.46B |
| 220 | TMDX | TransMedics Group, Inc. | 2.50B | -0.47% | 627,689 | 668.47M |
| 221 | HCM | HUTCHMED (China) Limited | 2.50B | -0.63% | 23,358 | 549.12M |
| 222 | ZLAB | Zai Lab Limited | 2.47B | -8.93% | 1,438,905 | 449.61M |
| 223 | RCUS | Arcus Biosciences, Inc. | 2.47B | 1.36% | 8,370,960 | 117.00M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.45B | -1.13% | 1,384,743 | 156.04M |
| 225 | ADMA | ADMA Biologics, Inc. | 2.45B | -0.54% | 3,551,452 | 512.28M |
| 226 | SUPN | Supernus Pharmaceuticals, Inc. | 2.45B | 2.09% | 937,418 | 830.44M |
| 227 | BKD | Brookdale Senior Living Inc. | 2.43B | 1.09% | 3,510,710 | 2.93B |
| 228 | MBX | MBX Biosciences, Inc. | 2.43B | -6.43% | 631,689 | - |
| 229 | BHC | Bausch Health Companies Inc. | 2.43B | 0.62% | 1,196,577 | 10.85B |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.34B | 5.16% | 1,087,720 | 1.95B |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | 3.21% | 660,902 | 1.10B |
| 232 | AUPH | Aurinia Pharmaceuticals Inc. | 2.31B | 2.54% | 780,426 | 311.51M |
| 233 | UFPT | UFP Technologies, Inc. | 2.30B | 2.49% | 83,489 | 631.64M |
| 234 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -6.51% | 6,512,781 | - |
| 235 | PGEN | Precigen, Inc. | 2.29B | -3.18% | 6,253,831 | 85.72M |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.28B | -1.36% | 877,930 | 158.00K |
| 237 | FTRE | Fortrea Holdings Inc. | 2.27B | -0.58% | 1,986,926 | 2.68B |
| 238 | PRGO | Perrigo Company plc | 2.27B | 2.89% | 1,782,795 | 4.14B |
| 239 | ADUS | Addus HomeCare Corporation | 2.24B | 4.00% | 147,467 | 1.48B |
| 240 | PGNY | Progyny, Inc. | 2.23B | 2.39% | 744,542 | 1.31B |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 0.03% | 931,099 | 98.34M |
| 242 | BHVN | Biohaven Ltd. | 2.22B | 25.02% | 30,510,497 | - |
| 243 | VCEL | Vericel Corporation | 2.20B | 4.96% | 604,931 | 306.30M |
| 244 | PHVS | Pharvaris N.V. | 2.15B | -0.16% | 347,233 | - |
| 245 | AXGN | Axogen, Inc. | 2.15B | 0.55% | 961,575 | 251.17M |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.14B | -1.65% | 17,735,730 | 54.86M |
| 247 | NEO | NeoGenomics, Inc. | 2.11B | -3.81% | 2,463,224 | 766.30M |
| 248 | TRLV | Trulieve Cannabis Corp. | 2.10B | -0.73% | 1,217,708 | 1.14B |
| 249 | INSP | Inspire Medical Systems, Inc. | 2.10B | 2.24% | 659,844 | 898.74M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | -5.95% | 2,905,188 | 959.90M |
| 251 | VERA | Vera Therapeutics, Inc. | 2.09B | -6.89% | 2,545,668 | - |
| 252 | IMNM | Immunome, Inc. | 2.07B | 1.44% | 1,761,577 | 4.02M |
| 253 | SGRY | Surgery Partners, Inc. | 2.06B | 3.25% | 2,906,280 | 3.37B |
| 254 | ALMR | Alamar Biosciences, Inc. | 2.06B | -5.50% | 675,196 | 100.42M |
| 255 | ZYME | Zymeworks Inc. | 2.02B | 1.14% | 757,276 | 37.13M |
| 256 | WGS | GeneDx Holdings Corp. | 2.00B | -2.61% | 549,513 | 454.43M |
| 257 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.99B | 0.39% | 4,805,856 | 940.61M |
| 258 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | 3.21% | 181,458 | 6.13M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.98B | 2.68% | 307,945 | 1.13B |
| 260 | XERS | Xeris Biopharma Holdings, Inc. | 1.98B | 0.65% | 1,410,645 | 335.41M |
| 261 | LMAT | LeMaitre Vascular, Inc. | 1.95B | 1.98% | 212,754 | 262.43M |
| 262 | ASTH | Astrana Health, Inc. | 1.95B | 1.77% | 213,875 | 3.84B |
| 263 | XNCR | Xencor, Inc. | 1.92B | 2.70% | 936,276 | 104.97M |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -2.05% | 1,235,359 | 1.97B |
| 265 | SEPN | Septerna, Inc. | 1.91B | 0.29% | 251,074 | 98.88M |
| 266 | MLYS | Mineralys Therapeutics, Inc. | 1.90B | 1.75% | 824,729 | - |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | 4.63% | 4,892,523 | 3.64B |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.89B | 1.99% | 762,551 | 245.82M |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.84B | 1.33% | 1,184,910 | - |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 0.68% | 406,012 | 1.00M |
| 271 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | -6.61% | 3,920,255 | 208.78M |
| 272 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -0.15% | 104,398 | - |
| 273 | BFLY | Butterfly Network, Inc. | 1.81B | -4.08% | 5,500,324 | 112.14M |
| 274 | AMN | AMN Healthcare Services, Inc. | 1.81B | 8.86% | 1,446,847 | 3.43B |
| 275 | MAZE | Maze Therapeutics, Inc. | 1.77B | -1.93% | 891,547 | 20.00M |
| 276 | VIR | Vir Biotechnology, Inc. | 1.76B | -1.32% | 987,074 | 303.23M |
| 277 | NVCR | NovoCure Limited | 1.76B | -3.14% | 1,059,796 | 699.19M |
| 278 | ATEC | Alphatec Holdings, Inc. | 1.75B | 4.60% | 3,180,348 | 815.05M |
| 279 | BRVE | Braveheart Bio, Inc. | 1.75B | 2.09% | 156,502 | - |
| 280 | ALHC | Alignment Healthcare, Inc. | 1.75B | -0.12% | 3,037,614 | 4.58B |
| 281 | ARDT | Ardent Health, Inc. | 1.74B | 2.49% | 330,719 | 6.41B |
| 282 | KLRA | Kailera Therapeutics, Inc. | 1.72B | 2.71% | 855,721 | - |
| 283 | URGN | UroGen Pharma Ltd. | 1.72B | -0.93% | 689,100 | 188.73M |
| 284 | ALVO | Alvotech | 1.71B | -6.63% | 926,987 | 494.61M |
| 285 | HCSG | Healthcare Services Group, Inc. | 1.70B | 14.19% | 1,337,798 | 1.88B |
| 286 | OMCL | Omnicell, Inc. | 1.69B | 2.06% | 428,844 | 1.25B |
| 287 | SDGR | Schrödinger, Inc. | 1.69B | -5.44% | 1,627,751 | 259.04M |
| 288 | PSNL | Personalis, Inc. | 1.69B | -0.50% | 2,694,769 | 69.67M |
| 289 | KMTS | Kestra Medical Technologies, Ltd. | 1.69B | 3.70% | 739,134 | 106.73M |
| 290 | MESO | Mesoblast Limited | 1.67B | -2.18% | 236,781 | 120.25M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.66B | 0.08% | 1,346,388 | 27.59M |
| 292 | IMCR | Immunocore Holdings plc | 1.65B | 0.09% | 283,249 | 430.78M |
| 293 | NUVB | Nuvation Bio Inc. | 1.65B | -3.09% | 5,805,180 | 169.90M |
| 294 | NVAX | Novavax, Inc. | 1.65B | -9.26% | 12,238,865 | 413.80M |
| 295 | GENB | Generate Biomedicines, Inc. | 1.64B | -2.44% | 498,911 | 26.48M |
| 296 | COAG | Hemab Therapeutics Holdings, Inc. | 1.63B | -1.36% | 368,982 | - |
| 297 | PAHC | Phibro Animal Health Corporation | 1.62B | 1.43% | 254,377 | 1.52B |
| 298 | CMPS | COMPASS Pathways plc | 1.61B | -1.77% | 1,342,259 | - |
| 299 | ABSI | Absci Corporation | 1.61B | -6.67% | 3,706,661 | 1.56M |
| 300 | SNDA | Sonida Senior Living, Inc. | 1.60B | 1.20% | 464,756 | 481.07M |
| 301 | QURE | uniQure N.V. | 1.60B | 1.85% | 1,546,358 | 18.67M |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | 2.09% | 454,415 | 978.38M |
| 303 | AZTA | Azenta, Inc. | 1.58B | -2.04% | 813,313 | 613.81M |
| 304 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | 0.19% | 2,374,049 | 717.00M |
| 305 | GPCR | Structure Therapeutics Inc. | 1.56B | -0.36% | 702,324 | - |
| 306 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -4.21% | 3,650,772 | 59.51M |
| 307 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | 0.87% | 844,273 | - |
| 308 | CERT | Certara, Inc. | 1.54B | -0.88% | 2,365,295 | 421.75M |
| 309 | KRSA | Korsana Biosciences, Inc. | 1.52B | 2.74% | 93,069 | - |
| 310 | INVA | Innoviva, Inc. | 1.52B | 0.72% | 452,066 | 440.00M |
| 311 | AGL | agilon health, inc. | 1.52B | -0.77% | 184,311 | 5.92B |
| 312 | CNMD | CONMED Corporation | 1.48B | 4.95% | 398,583 | 1.37B |
| 313 | NBTX | Nanobiotix S.A. | 1.48B | 13.01% | 216,509 | 13.15M |
| 314 | PNTG | The Pennant Group, Inc. | 1.48B | 2.90% | 191,410 | 1.10B |
| 315 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.01% | 2,145,005 | 52.06M |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 1,050,969 | 746.16M |
| 317 | ANAB | AnaptysBio, Inc. | 1.44B | 0.33% | 254,904 | 106.09M |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.43B | 1.31% | 826,145 | - |
| 319 | ETON | Eton Pharmaceuticals, Inc. | 1.43B | 1.46% | 483,677 | 105.60M |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -1.11% | 249,508 | 1.30M |
| 321 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | -1.59% | 1,150,442 | - |
| 322 | NUTX | Nutex Health Inc. | 1.41B | 4.29% | 129,770 | 846.72M |
| 323 | FRNM | Freenome, Inc. | 1.41B | -6.50% | 586,697 | 35.41M |
| 324 | DMRA | Damora Therapeutics, Inc. | 1.34B | 0.84% | 420,640 | - |
| 325 | AAPG | Ascentage Pharma Group International | 1.34B | -8.69% | 18,788 | 94.61M |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.32B | 2.84% | 129,976 | 804.27M |
| 327 | NKTR | Nektar Therapeutics | 1.32B | 0.99% | 1,022,166 | 54.59M |
| 328 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -2.79% | 3,105,090 | 5.49M |
| 329 | INNV | InnovAge Holding Corp. | 1.30B | 4.16% | 950,826 | 989.71M |
| 330 | RAPP | Rapport Therapeutics, Inc. | 1.27B | 5.87% | 1,459,439 | 20.00M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.27B | 0.48% | 230,853 | - |
| 332 | CRON | Cronos Group Inc. | 1.27B | 1.62% | 995,558 | 179.09M |
| 333 | GHRS | GH Research PLC | 1.27B | -2.17% | 329,102 | - |
| 334 | BVS | Bioventus Inc. | 1.26B | 5.62% | 593,044 | 581.85M |
| 335 | ENOV | Enovis Corporation | 1.25B | 3.75% | 1,295,354 | 2.30B |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.23B | 1.40% | 727,136 | 785.23M |
| 337 | VSTM | Verastem, Inc. | 1.22B | 9.23% | 5,947,039 | 87.53M |
| 338 | OMER | Omeros Corporation | 1.22B | 3.69% | 737,274 | 38.42M |
| 339 | OPK | OPKO Health, Inc. | 1.22B | 1.87% | 2,194,961 | 587.90M |
| 340 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21B | 3.19% | 2,362,680 | 252.25M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.21B | 9.08% | 286,743 | - |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | 4.89% | 1,871,149 | 1.04B |
| 343 | KARD | Kardigan, Inc. | 1.19B | -0.86% | 380,787 | - |
| 344 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -4.30% | 447,629 | - |
| 345 | SLN | Silence Therapeutics plc | 1.18B | -0.05% | 3,078,637 | 615.00K |
| 346 | AORT | Artivion, Inc. | 1.17B | 4.67% | 544,401 | 471.47M |
| 347 | BCAX | Bicara Therapeutics Inc. | 1.17B | -1.68% | 816,891 | - |
| 348 | OMDA | Omada Health, Inc. | 1.16B | -3.46% | 686,703 | 309.76M |
| 349 | SVRA | Savara Inc. | 1.15B | -2.78% | 2,709,761 | - |
| 350 | TDOC | Teladoc Health, Inc. | 1.15B | 0.32% | 2,817,496 | 2.49B |
| 351 | PRCT | PROCEPT BioRobotics Corporation | 1.15B | 9.63% | 1,191,493 | 337.34M |
| 352 | REPL | Replimune Group, Inc. | 1.13B | 2.30% | 1,760,788 | - |
| 353 | STAA | STAAR Surgical Company | 1.13B | 4.07% | 416,254 | 339.59M |
| 354 | IRMD | IRADIMED CORPORATION | 1.12B | -0.19% | 93,076 | 86.34M |
| 355 | VOR | Vor Biopharma Inc. | 1.12B | - | 723,515 | - |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.11B | 5.52% | 131,419 | - |
| 357 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | -0.61% | 315,001 | 730.02M |
| 358 | LTGO | Latigo Biotherapeutics, Inc. | 1.10B | 1.41% | 119,376 | - |
| 359 | HSTM | HealthStream, Inc. | 1.06B | 3.22% | 189,535 | 321.12M |
| 360 | HROW | Harrow, Inc. | 1.06B | -0.32% | 440,112 | 275.59M |
| 361 | CBLL | CeriBell, Inc. | 1.05B | 0.96% | 368,293 | 101.96M |
| 362 | MLTX | MoonLake Immunotherapeutics | 1.05B | 15.87% | 6,120,090 | - |
| 363 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | 0.74% | 307,095 | 1.04B |
| 364 | AHG | Akso Health Group | 1.05B | -3.94% | - | 13.83M |
| 365 | JANX | Janux Therapeutics, Inc. | 1.04B | 0.77% | 514,246 | 24.00M |
| 366 | CTY | City Therapeutics, Inc. | 1.03B | 1.66% | 127,586 | 14.34M |
| 367 | IMTX | Immatics N.V. | 1.03B | -1.95% | 621,016 | 47.65M |
| 368 | MNKD | MannKind Corporation | 1.03B | 4.92% | 3,252,267 | 393.63M |
| 369 | BBNX | Beta Bionics, Inc. | 1.02B | 5.19% | 685,195 | 119.01M |
| 370 | CSTL | Castle Biosciences, Inc. | 1.01B | -3.55% | 335,391 | 357.28M |
| 371 | SIBN | SI-BONE, Inc. | 966.29M | 3.55% | 527,759 | 213.60M |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 960.17M | 0.20% | 392,651 | - |
| 373 | IART | Integra LifeSciences Holdings Corporation | 958.55M | 4.10% | 1,386,959 | 1.66B |
| 374 | JBIO | Jade Biosciences, Inc. | 948.24M | -1.45% | 575,925 | - |
| 375 | GLUE | Monte Rosa Therapeutics, Inc. | 947.83M | -0.98% | 1,284,512 | 28.73M |
| 376 | AVBP | ArriVent BioPharma, Inc. | 946.71M | 0.42% | 843,599 | - |
| 377 | SGP | SpyGlass Pharma, Inc. | 943.90M | 1.77% | 91,317 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 938.34M | -0.91% | 471,917 | 397.50M |
| 379 | AKTS | Aktis Oncology, Inc. | 932.18M | 2.07% | 186,963 | 10.06M |
| 380 | QDEL | QuidelOrtho Corporation | 924.40M | -4.26% | 1,643,058 | 2.67B |
| 381 | ODTX | Odyssey Therapeutics, Inc. | 914.28M | 0.42% | 141,753 | 99.00K |
| 382 | RIGL | Rigel Pharmaceuticals, Inc. | 912.70M | -0.04% | 152,639 | 276.79M |
| 383 | CRVS | Corvus Pharmaceuticals, Inc. | 895.89M | 5.97% | 1,080,556 | - |
| 384 | ALMS | Alumis Inc. | 882.75M | 0.15% | 1,503,406 | 7.40M |
| 385 | KURA | Kura Oncology, Inc. | 877.15M | -0.20% | 1,061,865 | 77.23M |
| 386 | ANRO | Alto Neuroscience, Inc. | 871.17M | -4.80% | 510,817 | - |
| 387 | OBX | Obsidian Therapeutics, Inc. | 861.11M | 0.07% | 174,494 | - |
| 388 | GMRS | GMR Solutions Inc. | 837.06M | 3.56% | 488,883 | 5.88B |
| 389 | ABUS | Arbutus Biopharma Corporation | 832.94M | 0.72% | 2,464,086 | 181.72M |
| 390 | AHCO | AdaptHealth Corp. | 823.13M | 1.15% | 2,181,361 | 3.36B |
| 391 | IVA | Inventiva S.A. | 821.92M | 1.41% | 2,399,497 | 2.81M |
| 392 | INMD | InMode Ltd. | 807.60M | 0.14% | 805,605 | 374.63M |
| 393 | ARDX | Ardelyx, Inc. | 797.40M | 2.24% | 2,723,800 | 450.89M |
| 394 | PHR | Phreesia, Inc. | 789.54M | 3.75% | 610,824 | 507.79M |
| 395 | VREX | Varex Imaging Corporation | 775.94M | -0.05% | 1,180,012 | 865.00M |
| 396 | APMD | Apnimed, Inc. | 771.42M | -1.96% | 194,811 | 115.12M |
| 397 | HELP | Helus Pharma Inc. | 767.13M | -2.60% | 1,915,947 | - |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 765.06M | 2.53% | 738,757 | 808.21M |
| 399 | PHAR | Pharming Group N.V. | 748.06M | 10.57% | 21,600 | 366.48M |
| 400 | SLBT | SL Science Holding Limited | 747.05M | -9.66% | 32,000 | 3.27M |
| 401 | GERN | Geron Corporation | 725.99M | -2.59% | 7,178,600 | 204.56M |
| 402 | ANNX | Annexon, Inc. | 722.30M | -1.30% | 3,665,144 | - |
| 403 | SANA | Sana Biotechnology, Inc. | 709.48M | 0.85% | 2,429,258 | - |
| 404 | CTKB | Cytek Biosciences, Inc. | 705.81M | -1.27% | 694,300 | 206.71M |
| 405 | SGMT | Sagimet Biosciences Inc. | 705.54M | -0.40% | 1,006,778 | - |
| 406 | STLN | Starling Oncology, Inc. | 704.24M | 1.17% | 871,697 | 587.24M |
| 407 | IAM | Iambic Therapeutics, Inc. | 695.37M | -7.15% | 497,477 | 18.25M |
| 408 | OABI | OmniAb, Inc. | 694.97M | -2.75% | 1,336,419 | 38.46M |
| 409 | IMMX | Immix Biopharma, Inc. | 692.24M | -1.88% | 817,855 | - |
| 410 | ANL | Adlai Nortye Group Ltd. | 681.33M | -6.04% | 169,967 | 18.06M |
| 411 | NVCT | Nuvectis Pharma, Inc. | 680.63M | 1.35% | 110,051 | - |
| 412 | AURA | Aura Biosciences, Inc. | 669.93M | - | 955,315 | - |
| 413 | ACHV | Achieve Life Sciences, Inc. | 668.87M | -0.15% | 963,280 | - |
| 414 | SLDB | Solid Biosciences Inc. | 663.72M | -3.43% | 1,217,087 | - |
| 415 | PRME | Prime Medicine, Inc. | 663.58M | -2.10% | 4,657,478 | 4.07M |
| 416 | LXRX | Lexicon Pharmaceuticals, Inc. | 662.98M | -4.49% | 1,320,435 | 41.47M |
| 417 | ATTO | Attovia Therapeutics, Inc. | 661.94M | 2.26% | 189,144 | 1.80M |
| 418 | WVE | Wave Life Sciences, Inc. | 660.11M | -0.59% | 1,847,408 | 65.37M |
| 419 | DSGN | Design Therapeutics, Inc. | 656.48M | -2.24% | 270,712 | - |
| 420 | FDMT | 4D Molecular Therapeutics, Inc. | 654.64M | -6.10% | 1,354,575 | 92.01M |
| 421 | DNA | Ginkgo Bioworks Holdings, Inc. | 653.87M | -3.00% | 1,979,120 | 132.42M |
| 422 | KIDS | OrthoPediatrics Corp. | 645.17M | 3.65% | 511,359 | 252.72M |
| 423 | CADL | Candel Therapeutics, Inc. | 641.23M | 0.12% | 762,579 | - |
| 424 | PACB | Pacific Biosciences of California, Inc. | 640.31M | -3.74% | 9,177,833 | 159.27M |
| 425 | CRMD | CorMedix Inc. | 631.35M | 3.98% | 1,092,071 | 462.25M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 621.36M | -0.85% | 66,575 | 109.82M |
| 427 | OLMA | Olema Pharmaceuticals, Inc. | 614.23M | -0.43% | 1,064,856 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 613.43M | -0.29% | 537,230 | 136.07M |
| 429 | CLYM | Climb Bio, Inc. | 605.38M | -3.04% | 654,057 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 600.15M | -4.08% | 353,203 | 86.17M |
| 431 | WEAV | Weave Communications, Inc. | 591.19M | - | 4,469,725 | 257.79M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 589.91M | 0.56% | 1,040,987 | 389.32M |
| 433 | AVR | Anteris Technologies Global Corp. | 584.96M | -0.17% | 2,096,158 | 2.24M |
| 434 | DBVT | DBV Technologies S.A. | 583.14M | 0.62% | 121,590 | 5.04M |
| 435 | PBYI | Puma Biotechnology, Inc. | 581.24M | 3.30% | 395,518 | 231.24M |
| 436 | ETRA | Electra Therapeutics, Inc. | 580.59M | 2.21% | 155,800 | - |
| 437 | MDXG | MiMedx Group, Inc. | 572.84M | 5.08% | 1,575,764 | 355.17M |
| 438 | EVO | Evotec SE | 565.55M | -1.28% | 51,811 | 819.47M |
| 439 | ACRS | Aclaris Therapeutics, Inc. | 563.77M | 0.52% | 2,799,134 | 8.22M |
| 440 | CBIO | Crescent Biopharma, Inc. | 562.41M | -0.23% | 163,324 | 11.88M |
| 441 | STTK | Shattuck Labs, Inc. | 562.03M | 0.36% | 1,220,822 | 1.00M |
| 442 | PHAT | Phathom Pharmaceuticals, Inc. | 556.80M | -0.28% | 811,712 | 239.66M |
| 443 | EVH | Evolent Health, Inc. | 552.86M | 1.24% | 1,312,923 | 2.10B |
| 444 | MYGN | Myriad Genetics, Inc. | 550.94M | 3.41% | 4,439,953 | 806.60M |
| 445 | FLGT | Fulgent Genetics, Inc. | 550.03M | -0.70% | 278,880 | 323.93M |
| 446 | TCMD | Tactile Systems Technology, Inc. | 533.23M | 1.12% | 134,592 | 350.31M |
| 447 | CTMX | CytomX Therapeutics, Inc. | 531.67M | 1.67% | 2,444,640 | 18.30M |
| 448 | ENTX | Entera Bio Ltd. | 525.25M | -0.98% | 629,441 | 42.00K |
| 449 | FTH | Faeth Therapeutics, Inc. | 519.39M | -2.28% | 314,494 | - |
| 450 | AQST | Aquestive Therapeutics, Inc. | 518.36M | 1.23% | 1,852,406 | 54.09M |
| 451 | DRUG | Bright Minds Biosciences Inc. | 514.32M | 4.46% | 221,304 | - |
| 452 | DCTH | Delcath Systems, Inc. | 511.81M | 0.34% | 401,181 | 95.42M |
| 453 | VALN | Valneva SE | 509.71M | -3.60% | 22,500 | 163.30M |
| 454 | ANGO | AngioDynamics, Inc. | 505.49M | 1.09% | 673,141 | 325.38M |
| 455 | ARVN | Arvinas, Inc. | 504.78M | 2.12% | 620,142 | 316.70M |
| 456 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 457 | BLSM | BlossomHill Therapeutics, Inc. | 502.52M | 1.67% | 97,971 | - |
| 458 | SGHT | Sight Sciences, Inc. | 500.75M | 4.48% | 225,088 | 83.38M |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 500.10M | -1.81% | 391,893 | - |
| 460 | OCS | Oculis Holding AG | 499.41M | 2.80% | 427,887 | 1.45M |
| 461 | EOLS | Evolus, Inc. | 489.43M | 0.14% | 621,347 | 316.49M |
| 462 | MNPR | Monopar Therapeutics Inc. | 487.17M | 0.32% | 122,549 | - |
| 463 | NGNE | Neurogene Inc. | 485.88M | -6.90% | 212,365 | 925.00K |
| 464 | RCEL | AVITA Medical, Inc. | 476.89M | 0.85% | 652,066 | 75.63M |
| 465 | SSII | SS Innovations International, Inc. | 474.91M | -1.66% | 33,997 | 52.40M |
| 466 | RGNX | REGENXBIO Inc. | 473.31M | - | 1,132,499 | 174.48M |
| 467 | NRC | NRC Health | 472.92M | 5.27% | 70,066 | 140.00M |
| 468 | BWAY | BrainsWay Ltd. | 469.36M | -4.51% | 69,809 | 60.70M |
| 469 | MASS | 908 Devices Inc. | 469.14M | -3.81% | 256,516 | 60.84M |
| 470 | CERS | Cerus Corporation | 465.52M | -3.35% | 1,627,025 | 221.55M |
| 471 | DMAC | DiaMedica Therapeutics Inc. | 465.38M | -0.69% | 87,987 | - |
| 472 | OVID | Ovid Therapeutics Inc. | 462.86M | -4.05% | 1,177,574 | 1.58M |
| 473 | INDP | Indaptus Therapeutics, Inc. | 459.21M | -5.38% | 224,169 | - |
| 474 | MPLT | MapLight Therapeutics, Inc. | 458.50M | 1.10% | 349,512 | - |
| 475 | AGMB | AgomAb Therapeutics NV | 456.04M | 1.65% | 84,321 | - |
| 476 | NPCE | NeuroPace, Inc. | 451.02M | 0.69% | 97,949 | 106.99M |
| 477 | SRZN | Surrozen, Inc. | 450.50M | 1.70% | 137,022 | 11.51M |
| 478 | KMDA | Kamada Ltd. | 448.55M | -0.64% | 49,167 | 191.85M |
| 479 | EIKN | Eikon Therapeutics, Inc. | 446.32M | 3.00% | 348,516 | - |
| 480 | PROK | ProKidney Corp. | 432.32M | -0.69% | 584,476 | 818.00K |
| 481 | ALLO | Allogene Therapeutics, Inc. | 431.86M | -6.02% | 8,296,760 | 4.64M |
| 482 | TLRY | Tilray Brands, Inc. | 429.72M | 0.34% | 6,465,513 | 963.10M |
| 483 | SPRY | ARS Pharmaceuticals, Inc. | 429.61M | 3.35% | 1,787,743 | 116.93M |
| 484 | PRTA | Prothena Corporation plc | 423.53M | 2.62% | 381,827 | 54.53M |
| 485 | ALT | Altimmune, Inc. | 422.10M | -2.69% | 3,094,225 | 31.00K |
| 486 | AUTL | Autolus Therapeutics plc | 420.54M | -2.47% | 1,920,107 | 117.39M |
| 487 | TRXB | TRex Bio, Inc. | 417.29M | 1.64% | 67,487 | - |
| 488 | SRTA | Strata Critical Medical, Inc. | 416.68M | -0.42% | 688,246 | 255.98M |
| 489 | ASMB | Assembly Biosciences, Inc. | 412.91M | -0.78% | 137,849 | 74.85M |
| 490 | TECX | Tectonic Therapeutic, Inc. | 412.30M | -3.43% | 251,375 | - |
| 491 | SI | Shoulder Innovations, Inc. | 411.17M | 2.12% | 57,974 | 60.06M |
| 492 | OFIX | Orthofix Medical Inc. | 406.92M | 2.57% | 336,770 | 833.19M |
| 493 | RZLT | Rezolute, Inc. | 404.90M | 4.32% | 1,355,631 | - |
| 494 | AVTX | Avalo Therapeutics, Inc. | 399.54M | -39.23% | 26,189,975 | 59.00K |
| 495 | CARL | Carlsmed, Inc. | 398.89M | 2.10% | 54,565 | 63.30M |
| 496 | CTEV | Claritev Corporation | 398.27M | 2.17% | 146,416 | 994.67M |
| 497 | CYH | Community Health Systems, Inc. | 394.38M | 3.19% | 1,708,427 | 11.98B |
| 498 | SENS | Senseonics Holdings, Inc. | 391.27M | -7.15% | 537,827 | 48.55M |
| 499 | CCCC | C4 Therapeutics, Inc. | 391.22M | 0.32% | 1,692,666 | 35.04M |
| 500 | EMBC | Embecta Corp. | 388.68M | 2.69% | 922,040 | 1.02B |